Oruka Therapeutics, Inc. Variable Lease, Cost
Oruka Therapeutics, Inc. (ORKA) reported Variable Lease, Cost of $200.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-11-12
- Oruka Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $200.00K, a 100.00% increase year-over-year.
- Oruka Therapeutics, Inc. variable lease, cost for the quarter ending 2025-06-30 was $300.00K, a 200.00% increase year-over-year.
- Oruka Therapeutics, Inc. variable lease, cost for the quarter ending 2025-03-31 was $100.00K.
- Oruka Therapeutics, Inc. variable lease, cost for the quarter ending 2024-09-30 was $100.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 5 month | Variable Lease, Cost 6 month | Variable Lease, Cost 8 month | Variable Lease, Cost 9 month |
|---|---|---|---|---|---|
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-12 | $500.00K derived: sum of 2 quarters · filed 2025-11-12 | $600.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $300.00K 10-Q · filed 2025-08-11 | $400.00K 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-14 | ||||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-12 | $200.00K derived: sum of 2 quarters · filed 2025-11-12 | $200.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-11 | $100.00K 10-Q · filed 2025-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |